Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Kuo

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
International Journal of Cancer|September 24, 2021
Afatinib treatment in a large real-world cohort of nonsmall cell lung cancer patients with common and uncommon epidermal growth factor receptor mutationChi-Hsien Huang, Jia-Shiuan Ju, Tzu-Hsuan Chiu, et al.
Clinical Medicine Insights. Oncology|July 8, 2025
Real-World Efficacy and Safety of S-1 Monotherapy in Non-Small Cell Lung Cancer Management: Insights From a Multicenter Retrospective Cohort StudyI-Lin Tsai, Chien-Yu Lin, Po-Lan Su, et al.
Thoracic Cancer|September 28, 2018
Impact of prolonged and early bevacizumab treatment on the overall survival of EGFR-mutant and EGFR-wild type nonsquamous non-small cell lung cancerYu-Chen Huang, Shih-Min Shen, Chien-Ying Liu, et al.
American Journal of Cancer Research|August 10, 2023
T790M detection rate after first-line combination therapy with bevacizumab and EGFR-TKIs in advanced NSCLC (TERRA Study)Chih-Hsi Scott Kuo, Po-Lan Su, Yu-Feng Wei, et al.
Frontiers in Immunology|November 7, 2022
Association of smoking status with non-small cell lung cancer patients harboring uncommon epidermal growth factor receptor mutationHow-Wen Ko, Shian-Sen Shie, Chih-Wei Wang, et al.
Scientific Reports|November 21, 2023
Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLCJia-Shiuan Ju, Allen Chung-Cheng Huang, Pi-Hung Tung, et al.
Therapeutic Advances in Medical Oncology|January 22, 2024
Differential prognostic value of tumor and plasma T790M mutations in EGFR TKI-treated advanced NSCLCPi-Hung Tung, Tzu-Hsuan Chiu, Allen Chung-Cheng Huang, et al.
Therapeutic Advances in Medical Oncology|March 17, 2025
Multivariable model for predicting 5-year survival in patients with EGFR-mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors: a retrospective studyQi-An Wang, I-Lin Tsai, Chien-Yu Lin, et al.
Frontiers in Immunology|February 28, 2018
Unique Immune Gene Expression Patterns in Bronchoalveolar Lavage and Tumor Adjacent Non-Neoplastic Lung Tissue in Non-Small Cell Lung CancerChih-Hsi Scott Kuo, Chien-Ying Liu, Stelios Pavlidis, et al.
American Journal of Respiratory and Critical Care Medicine|September 1, 2016
A Transcriptome-driven Analysis of Epithelial Brushings and Bronchial Biopsies to Define Asthma Phenotypes in U-BIOPREDChih-Hsi Scott Kuo, Stelios Pavlidis, Matthew Loza, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
International Journal of Cancer|September 24, 2021
Afatinib treatment in a large real-world cohort of nonsmall cell lung cancer patients with common and uncommon epidermal growth factor receptor mutationChi-Hsien Huang, Jia-Shiuan Ju, Tzu-Hsuan Chiu, et al.
Clinical Medicine Insights. Oncology|July 8, 2025
Real-World Efficacy and Safety of S-1 Monotherapy in Non-Small Cell Lung Cancer Management: Insights From a Multicenter Retrospective Cohort StudyI-Lin Tsai, Chien-Yu Lin, Po-Lan Su, et al.
Thoracic Cancer|September 28, 2018
Impact of prolonged and early bevacizumab treatment on the overall survival of EGFR-mutant and EGFR-wild type nonsquamous non-small cell lung cancerYu-Chen Huang, Shih-Min Shen, Chien-Ying Liu, et al.
American Journal of Cancer Research|August 10, 2023
T790M detection rate after first-line combination therapy with bevacizumab and EGFR-TKIs in advanced NSCLC (TERRA Study)Chih-Hsi Scott Kuo, Po-Lan Su, Yu-Feng Wei, et al.
Frontiers in Immunology|November 7, 2022
Association of smoking status with non-small cell lung cancer patients harboring uncommon epidermal growth factor receptor mutationHow-Wen Ko, Shian-Sen Shie, Chih-Wei Wang, et al.
Scientific Reports|November 21, 2023
Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLCJia-Shiuan Ju, Allen Chung-Cheng Huang, Pi-Hung Tung, et al.
Therapeutic Advances in Medical Oncology|January 22, 2024
Differential prognostic value of tumor and plasma T790M mutations in EGFR TKI-treated advanced NSCLCPi-Hung Tung, Tzu-Hsuan Chiu, Allen Chung-Cheng Huang, et al.
Therapeutic Advances in Medical Oncology|March 17, 2025
Multivariable model for predicting 5-year survival in patients with EGFR-mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors: a retrospective studyQi-An Wang, I-Lin Tsai, Chien-Yu Lin, et al.
Frontiers in Immunology|February 28, 2018
Unique Immune Gene Expression Patterns in Bronchoalveolar Lavage and Tumor Adjacent Non-Neoplastic Lung Tissue in Non-Small Cell Lung CancerChih-Hsi Scott Kuo, Chien-Ying Liu, Stelios Pavlidis, et al.
American Journal of Respiratory and Critical Care Medicine|September 1, 2016
A Transcriptome-driven Analysis of Epithelial Brushings and Bronchial Biopsies to Define Asthma Phenotypes in U-BIOPREDChih-Hsi Scott Kuo, Stelios Pavlidis, Matthew Loza, et al.
Pageof 4